Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).

Albert FontBegona MelladoMiguel A ClimentJuan Antonio VirizuelaStephane OudardJavier PuenteDaniel CastellanoAranzazu González-Del-AlbaAlvaro PintoRafael Morales-BarreraAlejo Rodriguez-VidaPedro L FernandezCristina TeixidoPedro JaresIban AldecoaNeil GibsonFlavio SolcaShoubhik MondalRobert M LorenceJosep SerraFrancisco X Real

Published in: British journal of cancer (2023)

NCT02780687.

Keyphrases

tyrosine kinase
spinal cord injury
epidermal growth factor receptor
genome wide
open label
advanced non small cell lung cancer
copy number
dna methylation